240 related articles for article (PubMed ID: 32334267)
1. Design, synthesis and discovery of 2(1H)-quinolone derivatives for the treatment of pulmonary fibrosis through inhibition of TGF-β/smad dependent and independent pathway.
Xue L; Deng D; Zheng S; Tang M; Yang Z; Pei H; Chen Y; Yang T; Liu K; Ye H; Chen L
Eur J Med Chem; 2020 Jul; 197():112259. PubMed ID: 32334267
[TBL] [Abstract][Full Text] [Related]
2. The Anti-fibrotic and Anti-inflammatory Potential of Bone Marrow-Derived Mesenchymal Stem Cells and Nintedanib in Bleomycin-Induced Lung Fibrosis in Rats.
Gad ES; Salama AAA; El-Shafie MF; Arafa HMM; Abdelsalam RM; Khattab M
Inflammation; 2020 Feb; 43(1):123-134. PubMed ID: 31646446
[TBL] [Abstract][Full Text] [Related]
3. Evogliptin attenuates bleomycin-induced lung fibrosis via inhibiting TGF-β/Smad signaling in fibroblast.
Ba YD; Sun JH; Zhao XX
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10790-10798. PubMed ID: 33155239
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of TGF-β1/Smad3 signaling by compound 5aa: A potential treatment for idiopathic pulmonary fibrosis.
An B; Fang Y; Wang L; Nie W; Wang M; Nie H; Wu C; Wang R
Bioorg Chem; 2024 Jun; 147():107374. PubMed ID: 38636433
[TBL] [Abstract][Full Text] [Related]
5. Cigarette smoking aggravates bleomycin-induced experimental pulmonary fibrosis.
Zhou LL; Wang M; Liu F; Lu YZ; Song LJ; Xiong L; Xiang F; He XL; Shuai SY; Xin JB; Ye H; Yu F; Ma WL
Toxicol Lett; 2019 Mar; 303():1-8. PubMed ID: 30572104
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of MEN1 gene in radiation-induced pulmonary fibrosis in mice.
Wei W; Zhang HY; Gong XK; Dong Z; Chen ZY; Wang R; Yi JX; Shen YN; Jin SZ
Gene; 2018 Dec; 678():252-260. PubMed ID: 30099020
[TBL] [Abstract][Full Text] [Related]
7. Zanubrutinib attenuates bleomycin-induced pulmonary fibrosis by inhibiting the TGF-β1 signaling pathway.
Chen S; Wei Y; Li S; Miao Y; Gu J; Cui Y; Liu Z; Liang J; Wei L; Li X; Zhou H; Yang C
Int Immunopharmacol; 2022 Dec; 113(Pt A):109316. PubMed ID: 36252483
[TBL] [Abstract][Full Text] [Related]
8. The inhibitory effect of ginsan on TGF-β mediated fibrotic process.
Ahn JY; Kim MH; Lim MJ; Park S; Lee SL; Yun YS; Song JY
J Cell Physiol; 2011 May; 226(5):1241-7. PubMed ID: 20945375
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent Smad pathways: the role of Smad3.
Yang F; Chung AC; Huang XR; Lan HY
Hypertension; 2009 Oct; 54(4):877-84. PubMed ID: 19667256
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of astragaloside IV on silica-induced pulmonary fibrosis via inactivating TGF-β1/Smad3 signaling.
Li N; Feng F; Wu K; Zhang H; Zhang W; Wang W
Biomed Pharmacother; 2019 Nov; 119():109387. PubMed ID: 31487583
[TBL] [Abstract][Full Text] [Related]
11. Total flavonoids of Oxytropis falcata Bunge have a positive effect on idiopathic pulmonary fibrosis by inhibiting the TGF-β1/Smad signaling pathway.
Li XZ; Wang XL; Wang YJ; Liang QK; Li Y; Chen YW; Ming HX
J Ethnopharmacol; 2022 Mar; 285():114858. PubMed ID: 34826543
[TBL] [Abstract][Full Text] [Related]
12. Vardenafil Activity in Lung Fibrosis and In Vitro Synergy with Nintedanib.
Bourne MH; Kottom TJ; Hebrink DM; Choudhury M; Leof EB; Limper AH
Cells; 2021 Dec; 10(12):. PubMed ID: 34944010
[TBL] [Abstract][Full Text] [Related]
13. M2 macrophages induce EMT through the TGF-β/Smad2 signaling pathway.
Zhu L; Fu X; Chen X; Han X; Dong P
Cell Biol Int; 2017 Sep; 41(9):960-968. PubMed ID: 28493530
[TBL] [Abstract][Full Text] [Related]
14. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
[TBL] [Abstract][Full Text] [Related]
15. Telomere shortening activates TGF-β/Smads signaling in lungs and enhances both lipopolysaccharide and bleomycin-induced pulmonary fibrosis.
Liu YY; Shi Y; Liu Y; Pan XH; Zhang KX
Acta Pharmacol Sin; 2018 Nov; 39(11):1735-1745. PubMed ID: 29925920
[TBL] [Abstract][Full Text] [Related]
16. Obaculactone protects against bleomycin-induced pulmonary fibrosis in mice.
Wang X; Ouyang Z; You Q; He S; Meng Q; Hu C; Wu X; Shen Y; Sun Y; Wu X; Xu Q
Toxicol Appl Pharmacol; 2016 Jul; 303():21-29. PubMed ID: 27180239
[TBL] [Abstract][Full Text] [Related]
17. Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-β signaling.
Oruqaj G; Karnati S; Vijayan V; Kotarkonda LK; Boateng E; Zhang W; Ruppert C; Günther A; Shi W; Baumgart-Vogt E
Proc Natl Acad Sci U S A; 2015 Apr; 112(16):E2048-57. PubMed ID: 25848047
[TBL] [Abstract][Full Text] [Related]
18. Suppression of SMOC2 reduces bleomycin (BLM)-induced pulmonary fibrosis by inhibition of TGF-β1/SMADs pathway.
Luo L; Wang CC; Song XP; Wang HM; Zhou H; Sun Y; Wang XK; Hou S; Pei FY
Biomed Pharmacother; 2018 Sep; 105():841-847. PubMed ID: 30021376
[TBL] [Abstract][Full Text] [Related]
19. Dual inhibition of α
Decaris ML; Schaub JR; Chen C; Cha J; Lee GG; Rexhepaj M; Ho SS; Rao V; Marlow MM; Kotak P; Budi EH; Hooi L; Wu J; Fridlib M; Martin SP; Huang S; Chen M; Muñoz M; Hom TF; Wolters PJ; Desai TJ; Rock F; Leftheris K; Morgans DJ; Lepist EI; Andre P; Lefebvre EA; Turner SM
Respir Res; 2021 Oct; 22(1):265. PubMed ID: 34666752
[TBL] [Abstract][Full Text] [Related]
20. DOCK2 contributes to pulmonary fibrosis by promoting lung fibroblast to myofibroblast transition.
Guo X; Adeyanju O; Sunil C; Mandlem V; Olajuyin A; Huang S; Chen SY; Idell S; Tucker TA; Qian G
Am J Physiol Cell Physiol; 2022 Jul; 323(1):C133-C144. PubMed ID: 35584329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
